HRP20100091T1 - Uporaba protu-aterotrombotičkog spoja za proizvodnju lijekova za liječenje cerebrovaskularnih oboljenja - Google Patents

Uporaba protu-aterotrombotičkog spoja za proizvodnju lijekova za liječenje cerebrovaskularnih oboljenja Download PDF

Info

Publication number
HRP20100091T1
HRP20100091T1 HR20100091T HRP20100091T HRP20100091T1 HR P20100091 T1 HRP20100091 T1 HR P20100091T1 HR 20100091 T HR20100091 T HR 20100091T HR P20100091 T HRP20100091 T HR P20100091T HR P20100091 T1 HRP20100091 T1 HR P20100091T1
Authority
HR
Croatia
Prior art keywords
formula
compound
sodium salt
chlorophenylsulfonyl
patients
Prior art date
Application number
HR20100091T
Other languages
English (en)
Croatian (hr)
Inventor
Fratacci Marie-Dominique
De Cordoue Agnes
Lerond Laurence
Verbeuren Tony
Rupin Alain
Lavielle Gilbert
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HRP20100091T1 publication Critical patent/HRP20100091T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20100091T 2006-04-07 2010-02-19 Uporaba protu-aterotrombotičkog spoja za proizvodnju lijekova za liječenje cerebrovaskularnih oboljenja HRP20100091T1 (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0603082A FR2899473B1 (fr) 2006-04-07 2006-04-07 Utilisation d'un compose anti-atherothrombotique pour l'obtention de medicaments destines au traitement des troubles vasculaires

Publications (1)

Publication Number Publication Date
HRP20100091T1 true HRP20100091T1 (hr) 2010-04-30

Family

ID=37084627

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100091T HRP20100091T1 (hr) 2006-04-07 2010-02-19 Uporaba protu-aterotrombotičkog spoja za proizvodnju lijekova za liječenje cerebrovaskularnih oboljenja

Country Status (40)

Country Link
US (1) US20070238785A1 (zh)
EP (2) EP2105132A1 (zh)
JP (1) JP2009532447A (zh)
KR (2) KR20070100658A (zh)
CN (2) CN101693025A (zh)
AP (1) AP2007003952A0 (zh)
AR (1) AR060288A1 (zh)
AT (1) ATE452633T1 (zh)
AU (1) AU2007201525A1 (zh)
BR (1) BRPI0701597A (zh)
CA (1) CA2582394A1 (zh)
CO (1) CO5820217A1 (zh)
CR (1) CR9020A (zh)
CY (1) CY1109793T1 (zh)
DE (1) DE602007003880D1 (zh)
DK (1) DK1842537T3 (zh)
EA (1) EA013874B1 (zh)
ES (1) ES2338600T3 (zh)
FR (1) FR2899473B1 (zh)
GE (1) GEP20094782B (zh)
GT (1) GT200700029A (zh)
HR (1) HRP20100091T1 (zh)
IL (1) IL182406A0 (zh)
MA (1) MA28988B1 (zh)
MX (1) MX2007004108A (zh)
NI (1) NI200700083A (zh)
NO (1) NO20071833L (zh)
NZ (1) NZ554348A (zh)
PE (1) PE20071147A1 (zh)
PL (1) PL1842537T3 (zh)
PT (1) PT1842537E (zh)
RS (1) RS51207B (zh)
SG (1) SG136882A1 (zh)
SI (1) SI1842537T1 (zh)
SV (1) SV2008003053A (zh)
TN (1) TNSN07117A1 (zh)
TW (1) TW200808306A (zh)
UY (1) UY30263A1 (zh)
WO (1) WO2007116138A1 (zh)
ZA (1) ZA200702866B (zh)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9102862D0 (en) * 1991-02-11 1991-03-27 Erba Carlo Spa N-imidazolyl derivatives of substituted or alkoxymino tetrahydronaphthalenes and chromans
RU2120292C1 (ru) * 1992-07-22 1998-10-20 Российско-германское акционерное общество закрытого типа "УТИЛЕКС" Способ лечения мозговых сосудистых кризов
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
DE4343776A1 (de) * 1993-12-17 1995-06-22 Schering Ag Cyclopentanonderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
JPH08119936A (ja) * 1994-10-18 1996-05-14 Fujisawa Pharmaceut Co Ltd 複素環式誘導体
FR2805261A1 (fr) * 2000-02-18 2001-08-24 Adir Nouveaux derives d'acides 6-amino ou 6-hydrazinosulfonyl-3- quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2857593B1 (fr) * 2003-07-18 2005-10-14 Servier Lab Composition pharmaceutique orodispersible d'un compose antithrombotique
FR2860436B1 (fr) * 2003-10-03 2006-01-20 Servier Lab Nouvelle association d'un anti-atherothrombotique et d'un antiagregant plaquettaire

Also Published As

Publication number Publication date
ZA200702866B (en) 2008-07-30
ES2338600T3 (es) 2010-05-10
DK1842537T3 (da) 2010-04-12
CO5820217A1 (es) 2007-11-30
JP2009532447A (ja) 2009-09-10
CN101693025A (zh) 2010-04-14
KR20070100658A (ko) 2007-10-11
RS51207B (sr) 2010-12-31
SG136882A1 (en) 2007-11-29
PL1842537T3 (pl) 2010-06-30
SI1842537T1 (sl) 2010-03-31
TW200808306A (en) 2008-02-16
EP1842537B1 (fr) 2009-12-23
AU2007201525A1 (en) 2007-10-25
US20070238785A1 (en) 2007-10-11
EA200700573A3 (ru) 2007-12-28
WO2007116138A1 (fr) 2007-10-18
AR060288A1 (es) 2008-06-04
CN101049292A (zh) 2007-10-10
EP1842537A1 (fr) 2007-10-10
KR20090086500A (ko) 2009-08-13
PT1842537E (pt) 2010-01-15
MX2007004108A (es) 2009-02-16
DE602007003880D1 (de) 2010-02-04
ATE452633T1 (de) 2010-01-15
AP2007003952A0 (en) 2007-04-30
GEP20094782B (en) 2009-09-25
EA013874B1 (ru) 2010-08-30
BRPI0701597A (pt) 2007-12-11
GT200700029A (es) 2007-10-31
CY1109793T1 (el) 2014-09-10
NZ554348A (en) 2008-09-26
UY30263A1 (es) 2007-05-31
FR2899473B1 (fr) 2008-06-13
IL182406A0 (en) 2008-01-20
MA28988B1 (fr) 2007-11-01
NO20071833L (no) 2007-10-08
EA200700573A2 (ru) 2007-10-26
EP2105132A1 (fr) 2009-09-30
NI200700083A (es) 2008-06-09
PE20071147A1 (es) 2007-12-22
TNSN07117A1 (fr) 2008-06-02
SV2008003053A (es) 2009-12-02
CR9020A (es) 2008-09-23
FR2899473A1 (fr) 2007-10-12
CA2582394A1 (fr) 2007-10-07

Similar Documents

Publication Publication Date Title
HRP20151425T1 (hr) Inhibitori indazola wnt signalnog puta i njihove terapeutske uporabe
CO6361928A2 (es) Modulares de aril metil benzoquinazolinona alostericos positivos del receptor m1
NO20076508L (no) Acyloksykarbamat prodroger av traneksaminsyre og fremgangsmater for fremstilling og anvendelse derav
HRP20150982T1 (hr) Novi modulatori sfingozin fosfat receptora
RS53591B1 (en) PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF INTERNAL HEARING DISORDERS
WO2005019163A3 (en) Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
BR112015029512A2 (pt) derivados de pirazolopirrolidina e seu uso no tratamento de doenças
RS52922B (en) PREPARATIONS FOR THE TREATMENT OF MULTIPLE SCLEROSIS AND THEIR USES
BR112015029491A2 (pt) derivados de imidazopirrolidinona e seu uso no tratamento de doença
UY30411A1 (es) Derivados sustituidos del acetato de 2,3,4,-tetrahidroimidazo-[1,5-a]-pirimidin-6-amina, composiciones farmacéuticas y aplicaciones
UA107578C2 (uk) Комбінована терапія при лікуванні діабету
BR112014003225A2 (pt) profármacos de treprostinil ligados a veículo
UA102517C2 (ru) Замещенные производные морфолина и тиоморфолина, фармацевтическая композиция на их основе и их применение для производства лекарственного средства для лечения расстройства или заболевания центральной нервной системы
HRP20110497T4 (hr) Postupci za primjenu kompozicija aminopiridina sa produženim oslobađanjem
EA201790406A1 (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
HRP20130007T1 (hr) Lijeäśenje kognitivnih poremeä†aja pomoä†u (r)-7-kloro-n-(kinuklidin-3-il)benzo[b]tiofen-2-karboksamida i njegovih farmaceutski prihvatljivih soli
EA201491606A1 (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
SI2760821T1 (en) A salt salt of an anti-inflammatory substituted cyclobutenedione compound
ES2455499T3 (es) Compuestos neuroprotectores y composiciones farmacéuticas que los comprenden
RU2011111117A (ru) Лечение аутоиммунных заболеваний
EA200901146A1 (ru) Твердые лекарственные формы, содержащие алискирен и его фармацевтически приемлемые соли
WO2008092072A3 (en) Modulators of the metabotropic glutamate receptor subtype 5 and uses thereof
BR112013026361A2 (pt) derivados de glicosídeo e usos dos mesmos
UY30029A1 (es) Derivados de piperidina, sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones
MEP42908A (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds